Logo image of CRMT

AMERICA'S CAR-MART INC (CRMT) Stock Fundamental Analysis

USA - NASDAQ:CRMT - US03062T1051 - Common Stock

26.79 USD
+1.92 (+7.72%)
Last: 10/20/2025, 2:49:36 PM
Fundamental Rating

3

CRMT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 119 industry peers in the Specialty Retail industry. There are concerns on the financial health of CRMT while its profitability can be described as average. CRMT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CRMT was profitable.
CRMT had a negative operating cash flow in the past year.
Of the past 5 years CRMT 4 years were profitable.
CRMT had a negative operating cash flow in each of the past 5 years.
CRMT Yearly Net Income VS EBIT VS OCF VS FCFCRMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M -150M

1.2 Ratios

The Return On Assets of CRMT (0.82%) is comparable to the rest of the industry.
The Return On Equity of CRMT (2.32%) is comparable to the rest of the industry.
CRMT has a Return On Invested Capital (4.57%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRMT is significantly below the industry average of 12.29%.
The 3 year average ROIC (3.44%) for CRMT is below the current ROIC(4.57%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.82%
ROE 2.32%
ROIC 4.57%
ROA(3y)0.14%
ROA(5y)4.28%
ROE(3y)0.19%
ROE(5y)9.25%
ROIC(3y)3.44%
ROIC(5y)7.19%
CRMT Yearly ROA, ROE, ROICCRMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

1.3 Margins

CRMT's Profit Margin of 0.95% is in line compared to the rest of the industry. CRMT outperforms 54.62% of its industry peers.
CRMT's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 6.23%, CRMT is doing good in the industry, outperforming 72.27% of the companies in the same industry.
CRMT's Operating Margin has declined in the last couple of years.
The Gross Margin of CRMT (48.39%) is better than 76.47% of its industry peers.
CRMT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.23%
PM (TTM) 0.95%
GM 48.39%
OM growth 3Y-15.53%
OM growth 5Y-7.04%
PM growth 3Y-45.5%
PM growth 5Y-28.51%
GM growth 3Y2.42%
GM growth 5Y-0.01%
CRMT Yearly Profit, Operating, Gross MarginsCRMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRMT is destroying value.
CRMT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CRMT has more shares outstanding
Compared to 1 year ago, CRMT has an improved debt to assets ratio.
CRMT Yearly Shares OutstandingCRMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
CRMT Yearly Total Debt VS Total AssetsCRMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.77, we must say that CRMT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.77, CRMT perfoms like the industry average, outperforming 40.34% of the companies in the same industry.
A Debt/Equity ratio of 1.38 is on the high side and indicates that CRMT has dependencies on debt financing.
CRMT has a worse Debt to Equity ratio (1.38) than 63.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF N/A
Altman-Z 1.77
ROIC/WACC0.51
WACC9.02%
CRMT Yearly LT Debt VS Equity VS FCFCRMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

CRMT has a Current Ratio of 1.29. This is a normal value and indicates that CRMT is financially healthy and should not expect problems in meeting its short term obligations.
CRMT's Current ratio of 1.29 is in line compared to the rest of the industry. CRMT outperforms 49.58% of its industry peers.
A Quick Ratio of 0.44 indicates that CRMT may have some problems paying its short term obligations.
CRMT's Quick ratio of 0.44 is in line compared to the rest of the industry. CRMT outperforms 43.70% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 0.44
CRMT Yearly Current Assets VS Current LiabilitesCRMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

5

3. Growth

3.1 Past

CRMT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 112.22%, which is quite impressive.
CRMT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -30.02% yearly.
Looking at the last year, CRMT shows a small growth in Revenue. The Revenue has grown by 0.79% in the last year.
CRMT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.31% yearly.
EPS 1Y (TTM)112.22%
EPS 3Y-55.08%
EPS 5Y-30.02%
EPS Q2Q%-360%
Revenue 1Y (TTM)0.79%
Revenue growth 3Y5.17%
Revenue growth 5Y13.31%
Sales Q2Q%-1.85%

3.2 Future

Based on estimates for the next years, CRMT will show a very strong growth in Earnings Per Share. The EPS will grow by 59.25% on average per year.
Based on estimates for the next years, CRMT will show a small growth in Revenue. The Revenue will grow by 4.33% on average per year.
EPS Next Y-11.98%
EPS Next 2Y81.79%
EPS Next 3Y59.25%
EPS Next 5YN/A
Revenue Next Year6.14%
Revenue Next 2Y5.93%
Revenue Next 3Y4.33%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRMT Yearly Revenue VS EstimatesCRMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CRMT Yearly EPS VS EstimatesCRMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 38.27, which means the current valuation is very expensive for CRMT.
The rest of the industry has a similar Price/Earnings ratio as CRMT.
CRMT's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.42.
The Price/Forward Earnings ratio is 6.54, which indicates a rather cheap valuation of CRMT.
Based on the Price/Forward Earnings ratio, CRMT is valued cheaper than 96.64% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CRMT to the average of the S&P500 Index (22.94), we can say CRMT is valued rather cheaply.
Industry RankSector Rank
PE 38.27
Fwd PE 6.54
CRMT Price Earnings VS Forward Price EarningsCRMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRMT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.32
CRMT Per share dataCRMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

CRMT's earnings are expected to grow with 59.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y81.79%
EPS Next 3Y59.25%

0

5. Dividend

5.1 Amount

No dividends for CRMT!.
Industry RankSector Rank
Dividend Yield N/A

AMERICA'S CAR-MART INC

NASDAQ:CRMT (10/20/2025, 2:49:36 PM)

26.79

+1.92 (+7.72%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)09-04 2025-09-04/bmo
Earnings (Next)11-13 2025-11-13/bmo
Inst Owners87.77%
Inst Owner Change-0.11%
Ins Owners15.1%
Ins Owner Change-14.82%
Market Cap221.82M
Analysts80
Price Target40.29 (50.39%)
Short Float %13.3%
Short Ratio6.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)-1.73%
DP0.3%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-73.22%
Min EPS beat(2)-175.75%
Max EPS beat(2)29.31%
EPS beat(4)2
Avg EPS beat(4)-14.19%
Min EPS beat(4)-175.75%
Max EPS beat(4)229.77%
EPS beat(8)2
Avg EPS beat(8)-126.43%
EPS beat(12)2
Avg EPS beat(12)-104.05%
EPS beat(16)4
Avg EPS beat(16)-78.81%
Revenue beat(2)1
Avg Revenue beat(2)-1.85%
Min Revenue beat(2)-6.84%
Max Revenue beat(2)3.14%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-6.84%
Max Revenue beat(4)8.15%
Revenue beat(8)4
Avg Revenue beat(8)-1.78%
Revenue beat(12)7
Avg Revenue beat(12)-0.02%
Revenue beat(16)11
Avg Revenue beat(16)1.45%
PT rev (1m)-21%
PT rev (3m)-24.76%
EPS NQ rev (1m)-26.25%
EPS NQ rev (3m)-73.25%
EPS NY rev (1m)-70.33%
EPS NY rev (3m)-70.33%
Revenue NQ rev (1m)-3.63%
Revenue NQ rev (3m)-4.69%
Revenue NY rev (1m)-2.58%
Revenue NY rev (3m)-3.82%
Valuation
Industry RankSector Rank
PE 38.27
Fwd PE 6.54
P/S 0.16
P/FCF N/A
P/OCF N/A
P/B 0.39
P/tB 0.41
EV/EBITDA 10.32
EPS(TTM)0.7
EY2.61%
EPS(NY)4.1
Fwd EY15.3%
FCF(TTM)-5.2
FCFYN/A
OCF(TTM)-4.8
OCFYN/A
SpS167.21
BVpS68.26
TBVpS65.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.82%
ROE 2.32%
ROCE 5.84%
ROIC 4.57%
ROICexc 4.6%
ROICexgc 4.68%
OM 6.23%
PM (TTM) 0.95%
GM 48.39%
FCFM N/A
ROA(3y)0.14%
ROA(5y)4.28%
ROE(3y)0.19%
ROE(5y)9.25%
ROIC(3y)3.44%
ROIC(5y)7.19%
ROICexc(3y)3.46%
ROICexc(5y)7.23%
ROICexgc(3y)3.51%
ROICexgc(5y)7.31%
ROCE(3y)4.38%
ROCE(5y)9.16%
ROICexcg growth 3Y-20.68%
ROICexcg growth 5Y-14.67%
ROICexc growth 3Y-20.88%
ROICexc growth 5Y-14.71%
OM growth 3Y-15.53%
OM growth 5Y-7.04%
PM growth 3Y-45.5%
PM growth 5Y-28.51%
GM growth 3Y2.42%
GM growth 5Y-0.01%
F-Score4
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF N/A
Debt/EBITDA 8.31
Cap/Depr 42.56%
Cap/Sales 0.24%
Interest Coverage 1.22
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 0.44
Altman-Z 1.77
F-Score4
WACC9.02%
ROIC/WACC0.51
Cap/Depr(3y)178.38%
Cap/Depr(5y)233.56%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.22%
EPS 3Y-55.08%
EPS 5Y-30.02%
EPS Q2Q%-360%
EPS Next Y-11.98%
EPS Next 2Y81.79%
EPS Next 3Y59.25%
EPS Next 5YN/A
Revenue 1Y (TTM)0.79%
Revenue growth 3Y5.17%
Revenue growth 5Y13.31%
Sales Q2Q%-1.85%
Revenue Next Year6.14%
Revenue Next 2Y5.93%
Revenue Next 3Y4.33%
Revenue Next 5YN/A
EBIT growth 1Y272.22%
EBIT growth 3Y-11.16%
EBIT growth 5Y5.33%
EBIT Next Year423.72%
EBIT Next 3Y97.66%
EBIT Next 5YN/A
FCF growth 1Y68.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y67.11%
OCF growth 3YN/A
OCF growth 5YN/A